Latest fiscal year 2026 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2026, Prestige Consumer Healthcare Inc. reported revenue of $1.09B, down 4.3% year over year. Operating margin was 28.4% and net margin 17.5%, on a free-cash-flow margin of 22.6% with capital expenditure at 1.0% of revenue. Every figure is computed directly from PBH's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2026 | $1.09B | 28.4% | 17.5% |
| FY2025 | $1.14B | 29.6% | 18.9% |
| FY2024 | $1.13B | 30.4% | 18.6% |
| FY2023 | $1.13B | -2.0% | -7.3% |
| FY2022 | $1.09B | 30.4% | 18.9% |
How does PBH compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.